1. Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study
- Author
-
Jan Eritsland, Eigil Fossum, Peter Andreas Claussen, Michael Abdelnoor, Kristin M Kvakkestad, and Sigrun Halvorsen
- Subjects
Adult ,Coronary angiography ,medicine.medical_specialty ,medicine.medical_treatment ,Primary angioplasty ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,03 medical and health sciences ,Age Distribution ,0302 clinical medicine ,Older patients ,St elevation myocardial infarction ,Angioplasty ,Internal medicine ,Long term survival ,Humans ,Medicine ,Hospital Mortality ,Prospective Studies ,Registries ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Angioplasty, Balloon, Coronary ,Propensity Score ,Prospective cohort study ,Aged ,Aged, 80 and over ,Norway ,business.industry ,Age Factors ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Survival Analysis ,Cardiology ,ST Elevation Myocardial Infarction ,Corrigendum ,Cardiology and Cardiovascular Medicine ,business - Abstract
We aimed to study in-hospital mortality and long-term survival in elderly compared to younger patients with ST-segment elevation myocardial infarction (STEMI) in the era of primary angioplasty.This was a prospective cohort study. All consecutive STEMI-patients admitted to our hospital between September 2005-December 2011 were included in a local registry. Predefined variables were registered during hospital admission. Vital status was obtained from the Norwegian Cause of Death Registry with censoring date 31 December 2011. Adjusted effects of age ⩾80 years on in-hospital- and long-term mortality were determined using propensity score analysis. Of 4525 registered STEMI patients, 600 (13%) were octogenarians or older. In-hospital mortality was 17% in patients ⩾80 years and 4% in patients80 years. In invasively treated patients (83% of patients ⩾80 years; 98% of patients80 years), in-hospital mortality was 13% and 3.4%, respectively. Median follow-up time was 2.5 years. Three-year cumulative survival was 52% in patients ⩾80 years vs 89% in patients80 years. In invasively treated patients ⩾80 years, three-year survival was 58%. The adjusted odds ratio of in-hospital mortality was 2.61 (1.94-3.52) and adjusted incidence rate ratio of long-term mortality was 4.07 (3.43-4.84) in very elderly compared to younger patients.Short-term prognosis was acceptable in very elderly STEMI patients, especially in the invasively treated subgroup. However, only 52% of STEMI patients ⩾80 years were alive after three years of follow-up. Very elderly patients had 2.6 times higher risk of in-hospital mortality and 4.1 times the risk of not surviving during long-term follow-up compared to patients80 years, after adjustment for confounding factors and selection bias.
- Published
- 2015